Pamela Stephenson, Chief Commercial Officer at ALBIREO PHARMA, INC. (ALBO), sold 3,548 shares at $43.90 ($156K) on 2023-01-19, disclosed to the SEC on 2023-01-20.
Open-market sale of $156k ALBO by Chief Commercial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $43.90 | 1,774 | $78K | 50.0% |
| 2 | $43.90 | 1,774 | $78K | 50.0% |
| Total | $43.90 avg | 3,548 | $156K | 100% |
| Filing → |
| ZYNE | SELL | 2023-06-15 | $40 | — | Filing → |
| ALBO | SELL | 2023-01-23 | $4K | — | Filing → |
| ALBO | SELL | 2022-12-27 | $9K | — | Filing → |